(Bloomberg) -- China’s housing regulator boosted oversight of China Evergrande Group’s bank accounts to protect funds earmarked for housing projects from being diverted to creditors. The developer’s funds must first be used for construction to ensure project delivery, according to people familiar with the plan. Most Read from BloombergSchool Reopenings Falter as U.S. Kids Near 1 Million Covid CasesIstanbul Turns Taps on Old Fountains, Joining Global Push for Free DrinksA Jewish Tradition Makes R
Shares of Cloudflare Inc. dropped 3.4% in premarket trading Friday, after Oppenheimer downgraded the cyber security company, citing valuation and increasing competition. Analyst Timothy Horan, cut his rating to perform, after being at outperform since he started coverage in October 2019, a month after the company went public. He removed his $130 price target, which the stock has already surpassed. The stock, which closed at a record $136.97 on Wednesday, has soared 78.5% year to date, while the
CHICAGO, September 24, 2021--Hyatt Hotels Corporation ("Hyatt" or the "Company") (NYSE: H), a leading global hospitality company, announced today that, in connection with its previously announced underwritten registered public offering of 7,000,000 shares of its Class A common stock, the underwriters have fully exercised their option to purchase an additional 1,050,000 shares from the Company. The exercise of this option increases the size of the offering to an aggregate of 8,050,000 shares at a
WILMINGTON, Del., September 24, 2021--AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada, today announced positive high-level results from the PROpel Phase III trial. LYNPARZA® (olaparib) in combination with abiraterone demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival (rPFS) versus standard-of-care abiraterone as a 1st-line treatment for men with metastatic castration-resistant prostate cancer (mCRPC)
HokuApps, a global player in next-generation digital transformation services, is pleased to announce that they are selected as the preferred technology partner by Enrichment TEAM Pte Ltd, a prominent and credible Student-care and Educational Centre based out of Singapore. As a part of this strategic collaboration, Enrichment TEAM will leverage HokuApps's application development platform in building a single integrated system. This solution will be uniquely customized to their ecosystem and will
Dublin, Sept. 24, 2021 (GLOBE NEWSWIRE) -- The "Pet Insurance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The Pet Insurance market is expected to register a CAGR of 7.1% during the forecast period. As per the American Veterinary Medical Association 2020, there was a survey conducted for practice owners wherein it was concluded that an increasing number of veterinary practices are using telemedicine, and precau
Home prices will likely rise in the next year, many experts think. Here’s what experts say about home price trends and whether you should buy now. Of course, no one has a crystal ball that can foresee the future of the real estate market, but a report from the National Association of Realtors revealed home prices will likely climb 5.5% in 2022.
The EU executive asked Warsaw on Friday to allow Frontex staff on the Polish-Belarusian border where four migrants died while trying to cross into Europe amid an increase in irregular immigration the bloc blames on Minsk for orchestrating. The spokesman said allowing border guards of the EU's joint frontier force Frontex was "a very good idea".
Major players in the neutropenia biologic drug treatment market are Teva Pharmaceutical, Amgen, Sanofi, Mylan, Kyowa Kirin, Baxter International, CVS Health Corp, Novartis, Spectrum Pharmaceuticals, and Partner Therapeutics.New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Neutropenia Biologic Drug Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030" - https://www.reportlinker.com/p06151681/?utm_source=GNW The global neutropeni
Although Congress still has to work out the major details, it's looking very likely that there will be trillions in infrastructure spending in the United States over the next decade or so. In this Fool Live video clip, recorded on Sept. 13, Senior Analyst Asit Sharma discusses why Deere & Co. (NYSE: DE) is one of his top ways to invest before the wave of spending begins. Asit Sharma: This company is Deere and Company symbol DE.